Showing results (581-590 of 1,271) with videos related to

Sort By:
Pageof 128
Psychopharmacology Bulletin|April 14, 2025
Challenges in Transitioning from Methadone to Buprenorphine-Naloxone for Chronic Pain Management: Two CasesJamal Hasoon, Anvinh Nguyen, Omar Viswanath, et al.
Psychopharmacology Bulletin|April 14, 2025
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to AdulthoodKeming Gao, Buket Koparal, Evrim Bayrak Oruc, et al.
Psychopharmacology Bulletin|March 13, 2026
Smoking Status Among Patients Presenting to a Chronic Pain Clinic: A Retrospective Review from a University-Affiliated Pain ClinicJamal Hasoon, Jacob Ng, John Spikes, et al.
Psychopharmacology Bulletin|March 13, 2026
Clavulanic Acid Attenuated Cocaine Craving in Individuals with Cocaine Use DisorderMary F Morrison, Ronan Cunningham, M Ingre Walters, et al.
Psychopharmacology Bulletin|March 13, 2026
Comparative Effectiveness of Naltrexone Formulations in Alcohol Use Disorder: An Updated Meta-AnalysisNicolas A Nunez, Hossam M Ali, Leslie Hassett, et al.
Psychopharmacology Bulletin|March 13, 2026
Efficacy and Safety of Asenapine in Bipolar Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMuneeb Ahmad Muneer, Hafsa, Umair Ahmed, et al.
Psychopharmacology Bulletin|March 13, 2026
Incidence and Risk Factors of Clozapine-Induced Neutropenia among Patients with Schizophrenia in Taif, Saudi ArabiaAhmed Salem Altowairqi, Anas Ibn Auf, Saeed Saeed Alghamdi
Psychopharmacology Bulletin|March 7, 2024
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with SchizophreniaAhmed Naguy, Saxby Pridmore, Bibi Alamiri
Psychopharmacology Bulletin|March 7, 2024
A Comprehensive Review of Lemborexant to Treat InsomniaMitchell C Fuller, Samuel F Carlson, Chris Grant, et al.
Psychopharmacology Bulletin|March 7, 2024
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of SuicideTimothy Whitaker, Kimberly F Farrand, Michael E Thase
Pageof 128